{
    "info": {
        "nct_id": "NCT05597345",
        "official_title": "Selinexor for the Treatment of Patients with Intermediate and High-Risk Smoldering Multiple Myeloma",
        "inclusion_criteria": "* Age >/= 18 years\n* Histologically confirmed diagnosis of SMM according to the IMWG definition: serum M-protein >/= 3 g/dL or BMPC >10% but <60%, or both.\n* Should not meet CRAB criteria: hypercalcemia, anemia, bone lesions, or renal insufficiency thought to be related to the plasma cell disorder.\n* Should have 1 of the following risk factors to be considered intermediate risk and 2 or more risk factors to be considered high-risk:\n* BMPC>/=20%\n* M-spike >/= 2g/dL\n* Involved to uninvolved sFLC ratio of >/= 20\n* normal hepatic function within 28 days prior to C1D1\n* Adequate renal function within 28 days prior to C1D1. Estimated creatinine clearance (CrCl) calculated using formula of Cockcroft and Gault. CrCl >/= 15 mL/min.\n* Adequate hematopoietic function within 28 days prior to C1D1: absolute neutrophil count (ANC)>/=1.5 x10^9/L, hemoglobin >/=10g/dL, platelets >/150x10^9/L.\n* Life expectancy of >12 months.\n* ECOG PS 0-1\n* Subjects with reproductive potential must use 2 highly effective methods of effective contraception or practice sexual abstinence throughout the study and continue for 6 months after the study has closed. Subjects who are surgically sterile (e.g., history of bilateral tubal ligation, hysterectomy, or whos partner is sterile are not required to use additional modes of contraception.\n* Ability to understand and willingness\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Meets criteria for symptomatic MM as defined by any of the following, determined to be related to the plasma cell disorder\n\n  * Hypercalcemia (corrected serum calcium >11.0 mg/dL)\n  * Renal insufficiency (creatinine >2.0 mg/dL)\n  * Anemia (hemoglobin <10g/dL)\n  * One or more osteolytic bone lesions on radiography, but more than one lesion required if <10% clonal bone marrow plasma cells. Based on MRI imaging, there must be more than one lesion >5mm in size.\n  * Clonal bone marrow plasma cells ≥60%\n  * An involved serum free light chain ≥ 100mg/L with the ratio of the involved/uninvolved free light chains also ≥100\n* Documented systemic light chain amyloidosis\n* Systemic corticosteroids >10mg prednisone (or equivalent) daily for other medical conditions.\n* Active invasive malignancy within the past 3 years that may affect the results or interfere with the interpretation of results of this study.\n* Non-invasive malignancy that was not treated with curative intent within the past 3 years that may affect the results or interfere with the interpretation of the results of this study.\n* Uncontrolled active infection requiring parenteral antibiotics, antivirals, or antifungals within 14 days of the receiving the first dose\n* Known active HIV infection without adequate anti-retroviral therapy\n* Active gastrointestinal dysfunction that prevents patient from swallowing tablets or may interfere with absorption of study treatment\n* Pregnant, breast feeding, or planning to become pregnant within 6 months after the end of treatment.\n* Subject of reproductive potential that is not willing to use two methods of highly effective contraception during treatment period and for 6 months after the end of treatment.\n* Any major medical or psychiatric disorder that, in the opinion of the investigator, might prevent the subject from completing the study or interfere with the interpretation of the study results.\n* Prior exposure to a SINE compound, including Selinexor.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Histologically confirmed diagnosis of SMM according to the IMWG definition: serum M-protein >/= 3 g/dL or BMPC >10% but <60%, or both.",
            "criterions": [
                {
                    "exact_snippets": "Histologically confirmed diagnosis of SMM",
                    "criterion": "smoldering multiple myeloma (SMM) diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis confirmation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "serum M-protein >/= 3 g/dL",
                    "criterion": "serum M-protein",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "g/dL"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "BMPC >10% but <60%",
                    "criterion": "bone marrow plasma cells (BMPC) percentage",
                    "requirements": [
                        {
                            "requirement_type": "range",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">",
                                        "value": 10,
                                        "unit": "%"
                                    },
                                    {
                                        "operator": "<",
                                        "value": 60,
                                        "unit": "%"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* normal hepatic function within 28 days prior to C1D1",
            "criterions": [
                {
                    "exact_snippets": "normal hepatic function within 28 days prior to C1D1",
                    "criterion": "hepatic function",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "normal"
                        },
                        {
                            "requirement_type": "time window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 28,
                                "unit": "days prior to C1D1"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Age >/= 18 years",
            "criterions": [
                {
                    "exact_snippets": "Age >/= 18 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 18,
                                        "unit": "years"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* BMPC>/=20%",
            "criterions": [
                {
                    "exact_snippets": "BMPC>/=20%",
                    "criterion": "bone marrow plasma cells (BMPC)",
                    "requirements": [
                        {
                            "requirement_type": "percentage",
                            "expected_value": {
                                "operator": ">=",
                                "value": 20,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* M-spike >/= 2g/dL",
            "criterions": [
                {
                    "exact_snippets": "M-spike >/= 2g/dL",
                    "criterion": "M-spike",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "g/dL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Should not meet CRAB criteria: hypercalcemia, anemia, bone lesions, or renal insufficiency thought to be related to the plasma cell disorder.",
            "criterions": [
                {
                    "exact_snippets": "Should not meet CRAB criteria: hypercalcemia",
                    "criterion": "hypercalcemia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Should not meet CRAB criteria: ... anemia",
                    "criterion": "anemia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Should not meet CRAB criteria: ... bone lesions",
                    "criterion": "bone lesions",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Should not meet CRAB criteria: ... renal insufficiency thought to be related to the plasma cell disorder",
                    "criterion": "renal insufficiency related to plasma cell disorder",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Life expectancy of >12 months.",
            "criterions": [
                {
                    "exact_snippets": "Life expectancy of >12 months",
                    "criterion": "life expectancy",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">",
                                "value": 12,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG PS 0-1",
            "criterions": [
                {
                    "exact_snippets": "ECOG PS 0-1",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Should have 1 of the following risk factors to be considered intermediate risk and 2 or more risk factors to be considered high-risk:",
            "criterions": [
                {
                    "exact_snippets": "Should have 1 of the following risk factors to be considered intermediate risk and 2 or more risk factors to be considered high-risk",
                    "criterion": "number of risk factors",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 1,
                                        "unit": "risk factors"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ability to understand and willingness",
            "criterions": [
                {
                    "exact_snippets": "Ability to understand",
                    "criterion": "cognitive ability to understand",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "willingness",
                    "criterion": "willingness to participate",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Involved to uninvolved sFLC ratio of >/= 20",
            "criterions": [
                {
                    "exact_snippets": "Involved to uninvolved sFLC ratio of >/= 20",
                    "criterion": "involved to uninvolved sFLC ratio",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 20,
                                "unit": ""
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate renal function within 28 days prior to C1D1. Estimated creatinine clearance (CrCl) calculated using formula of Cockcroft and Gault. CrCl >/= 15 mL/min.",
            "criterions": [
                {
                    "exact_snippets": "Adequate renal function within 28 days prior to C1D1",
                    "criterion": "renal function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 28,
                                "unit": "days prior to C1D1"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Estimated creatinine clearance (CrCl) calculated using formula of Cockcroft and Gault. CrCl >/= 15 mL/min.",
                    "criterion": "creatinine clearance (CrCl)",
                    "requirements": [
                        {
                            "requirement_type": "estimation method",
                            "expected_value": "Cockcroft and Gault formula"
                        },
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 15,
                                "unit": "mL/min"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate hematopoietic function within 28 days prior to C1D1: absolute neutrophil count (ANC)>/=1.5 x10^9/L, hemoglobin >/=10g/dL, platelets >/150x10^9/L.",
            "criterions": [
                {
                    "exact_snippets": "Adequate hematopoietic function within 28 days prior to C1D1: absolute neutrophil count (ANC)>/=1.5 x10^9/L",
                    "criterion": "absolute neutrophil count (ANC)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1.5,
                                "unit": "x10^9/L"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate hematopoietic function within 28 days prior to C1D1: ... hemoglobin >/=10g/dL",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10,
                                "unit": "g/dL"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate hematopoietic function within 28 days prior to C1D1: ... platelets >/150x10^9/L",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 150,
                                "unit": "x10^9/L"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Hypercalcemia (corrected serum calcium >11.0 mg/dL)",
            "criterions": [
                {
                    "exact_snippets": "Hypercalcemia (corrected serum calcium >11.0 mg/dL)",
                    "criterion": "corrected serum calcium",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 11.0,
                                "unit": "mg/dL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active invasive malignancy within the past 3 years that may affect the results or interfere with the interpretation of results of this study.",
            "criterions": [
                {
                    "exact_snippets": "Active invasive malignancy within the past 3 years",
                    "criterion": "invasive malignancy",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "invasiveness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Systemic corticosteroids >10mg prednisone (or equivalent) daily for other medical conditions.",
            "criterions": [
                {
                    "exact_snippets": "Systemic corticosteroids >10mg prednisone (or equivalent) daily for other medical conditions.",
                    "criterion": "systemic corticosteroid use",
                    "requirements": [
                        {
                            "requirement_type": "dosage",
                            "expected_value": {
                                "operator": ">",
                                "value": 10,
                                "unit": "mg prednisone (or equivalent) daily"
                            }
                        },
                        {
                            "requirement_type": "indication",
                            "expected_value": "other medical conditions"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Non-invasive malignancy that was not treated with curative intent within the past 3 years that may affect the results or interfere with the interpretation of the results of this study.",
            "criterions": [
                {
                    "exact_snippets": "Non-invasive malignancy that was not treated with curative intent within the past 3 years",
                    "criterion": "non-invasive malignancy",
                    "requirements": [
                        {
                            "requirement_type": "treatment with curative intent within the past 3 years",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "may affect the results or interfere with the interpretation of the results of this study",
                    "criterion": "potential to affect study results or interpretation",
                    "requirements": [
                        {
                            "requirement_type": "potential to affect results or interpretation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Meets criteria for symptomatic MM as defined by any of the following, determined to be related to the plasma cell disorder",
            "criterions": [
                {
                    "exact_snippets": "Meets criteria for symptomatic MM",
                    "criterion": "symptomatic multiple myeloma (MM)",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "determined to be related to the plasma cell disorder",
                    "criterion": "relation to plasma cell disorder",
                    "requirements": [
                        {
                            "requirement_type": "relation",
                            "expected_value": "related"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any major medical or psychiatric disorder that, in the opinion of the investigator, might prevent the subject from completing the study or interfere with the interpretation of the study results.",
            "criterions": [
                {
                    "exact_snippets": "Any major medical or psychiatric disorder",
                    "criterion": "major medical disorder",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Any major medical or psychiatric disorder",
                    "criterion": "major psychiatric disorder",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Uncontrolled active infection requiring parenteral antibiotics, antivirals, or antifungals within 14 days of the receiving the first dose",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled active infection requiring parenteral antibiotics, antivirals, or antifungals within 14 days of the receiving the first dose",
                    "criterion": "active infection",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        },
                        {
                            "requirement_type": "treatment requirement",
                            "expected_value": [
                                "parenteral antibiotics",
                                "parenteral antivirals",
                                "parenteral antifungals"
                            ]
                        },
                        {
                            "requirement_type": "time window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days"
                            }
                        },
                        {
                            "requirement_type": "activity status",
                            "expected_value": "active"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active gastrointestinal dysfunction that prevents patient from swallowing tablets or may interfere with absorption of study treatment",
            "criterions": [
                {
                    "exact_snippets": "Active gastrointestinal dysfunction that prevents patient from swallowing tablets",
                    "criterion": "gastrointestinal dysfunction",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "effect on swallowing tablets",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Active gastrointestinal dysfunction that ... may interfere with absorption of study treatment",
                    "criterion": "gastrointestinal dysfunction",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "effect on absorption of study treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Pregnant, breast feeding, or planning to become pregnant within 6 months after the end of treatment.",
            "criterions": [
                {
                    "exact_snippets": "Pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "breast feeding",
                    "criterion": "breast feeding status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "planning to become pregnant within 6 months after the end of treatment",
                    "criterion": "pregnancy intention within 6 months after treatment",
                    "requirements": [
                        {
                            "requirement_type": "intention",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Documented systemic light chain amyloidosis",
            "criterions": [
                {
                    "exact_snippets": "Documented systemic light chain amyloidosis",
                    "criterion": "systemic light chain amyloidosis",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis/documentation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Clonal bone marrow plasma cells ≥60%",
            "criterions": [
                {
                    "exact_snippets": "Clonal bone marrow plasma cells ≥60%",
                    "criterion": "clonal bone marrow plasma cells",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known active HIV infection without adequate anti-retroviral therapy",
            "criterions": [
                {
                    "exact_snippets": "Known active HIV infection",
                    "criterion": "HIV infection",
                    "requirements": [
                        {
                            "requirement_type": "activity status",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "awareness",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "without adequate anti-retroviral therapy",
                    "criterion": "anti-retroviral therapy",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior exposure to a SINE compound, including Selinexor.",
            "criterions": [
                {
                    "exact_snippets": "Prior exposure to a SINE compound",
                    "criterion": "prior exposure to a SINE compound",
                    "requirements": [
                        {
                            "requirement_type": "history of exposure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "including Selinexor",
                    "criterion": "prior exposure to Selinexor",
                    "requirements": [
                        {
                            "requirement_type": "history of exposure",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* One or more osteolytic bone lesions on radiography, but more than one lesion required if <10% clonal bone marrow plasma cells. Based on MRI imaging, there must be more than one lesion >5mm in size.",
            "criterions": [
                {
                    "exact_snippets": "One or more osteolytic bone lesions on radiography",
                    "criterion": "osteolytic bone lesions on radiography",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "lesion"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "more than one lesion required if <10% clonal bone marrow plasma cells",
                    "criterion": "osteolytic bone lesions on radiography (conditional on clonal bone marrow plasma cells)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 1,
                                "unit": "lesion"
                            }
                        },
                        {
                            "requirement_type": "clonal bone marrow plasma cells",
                            "expected_value": {
                                "operator": "<",
                                "value": 10,
                                "unit": "%"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Based on MRI imaging, there must be more than one lesion >5mm in size",
                    "criterion": "bone lesions on MRI imaging",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 1,
                                "unit": "lesion"
                            }
                        },
                        {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": ">",
                                "value": 5,
                                "unit": "mm"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject of reproductive potential that is not willing to use two methods of highly effective contraception during treatment period and for 6 months after the end of treatment.",
            "criterions": [
                {
                    "exact_snippets": "Subject of reproductive potential",
                    "criterion": "reproductive potential",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "not willing to use two methods of highly effective contraception during treatment period and for 6 months after the end of treatment",
                    "criterion": "contraception use",
                    "requirements": [
                        {
                            "requirement_type": "willingness to use contraception",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "number of methods",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "methods"
                            }
                        },
                        {
                            "requirement_type": "contraception effectiveness",
                            "expected_value": "highly effective"
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": "during treatment period and for 6 months after the end of treatment"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Renal insufficiency (creatinine >2.0 mg/dL)",
            "criterions": [
                {
                    "exact_snippets": "Renal insufficiency (creatinine >2.0 mg/dL)",
                    "criterion": "renal insufficiency",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "creatinine >2.0 mg/dL",
                    "criterion": "creatinine",
                    "requirements": [
                        {
                            "requirement_type": "level",
                            "expected_value": {
                                "operator": ">",
                                "value": 2.0,
                                "unit": "mg/dL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Anemia (hemoglobin <10g/dL)",
            "criterions": [
                {
                    "exact_snippets": "Anemia (hemoglobin <10g/dL)",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 10,
                                "unit": "g/dL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* An involved serum free light chain ≥ 100mg/L with the ratio of the involved/uninvolved free light chains also ≥100",
            "criterions": [
                {
                    "exact_snippets": "involved serum free light chain ≥ 100mg/L",
                    "criterion": "involved serum free light chain",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100,
                                "unit": "mg/L"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "ratio of the involved/uninvolved free light chains also ≥100",
                    "criterion": "ratio of involved to uninvolved free light chains",
                    "requirements": [
                        {
                            "requirement_type": "ratio",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100,
                                "unit": ""
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "* Subjects with reproductive potential must use 2 highly effective methods of effective contraception or practice sexual abstinence throughout the study and continue for 6 months after the study has closed. Subjects who are surgically sterile (e.g., history of bilateral tubal ligation, hysterectomy, or whos partner is sterile are not required to use additional modes of contraception.",
            "criterions": [
                {
                    "exact_snippets": "Subjects with reproductive potential must use 2 highly effective methods of effective contraception or practice sexual abstinence throughout the study and continue for 6 months after the study has closed.",
                    "criterion": "contraception or sexual abstinence",
                    "requirements": [
                        {
                            "requirement_type": "use of contraception or abstinence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "number of methods",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "N/A"
                            }
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": "throughout the study and continue for 6 months after the study has closed"
                        }
                    ]
                },
                {
                    "exact_snippets": "Subjects who are surgically sterile (e.g., history of bilateral tubal ligation, hysterectomy, or whose partner is sterile) are not required to use additional modes of contraception.",
                    "criterion": "surgical sterility or partner sterility",
                    "requirements": [
                        {
                            "requirement_type": "sterility status",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}